Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: Their role in the formation of stable and unstable carotid atherosclerotic plaques

Surgical Neurology

Volumn 62, Issue 4, 2004, Pages 292-301

  Morioka, Motohiro ^a   Hamada, Jun Ichiro ^a   Hashiguchi, Akihito ^a   Hasegawa, Yu ^a   Todaka, Tatemi ^a   Yano, Shigetoshi ^a   Kai, Yutaka ^a   Miura, Masaki ^b   Fujioka, Shodo ^c   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO CITY HOSPITAL   (Japan)

^c SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

Author keywords

Carotid atherosclerosis; immunohistochemistry; ischemic stroke

Indexed keywords

ANGIOTENSIN; ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER;

ACTINS; AGED; ANGIOTENSIN II; ANTIGENS, CD31; ARTERIOSCLEROSIS; BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A;

EID: 4644243832     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2004.02.027     Document Type: Article

References (45)

1. Aberg G., Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 15:(Suppl 5):1990;S65-S72
2. Bassiouny H.S., Davis H., Massawa N., et al. Critical carotid stenoses morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg. 9:1989;202-212
3. Bassiouny H.S., Sakaguchi Y., Mikucki S.A., et al. Juxtaluminal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg. 26:1997;585-594
4. Caldwell P.R., Seegal B.C., Hsu K.C. Angiotensin-converting enzyme vascular endothelial localization. Science. 191:1976;1050-1051
5. Carr S., Farb A., Pearce W.H., et al. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 23:1996;755-766
6. Chobanian A.V., Haudenschild C.C., Nickerson C. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 15:1990;327-331
7. Daemen M.J.A.P., Lombardi D.M., Bosman F.T., et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:1991;450-456
8. Davies M.J., Richardson P.D., Woolf N., et al. Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage and smooth muscle content. Br Heart J. 69:1993;377-381
9. Davies M.J., Thomas A.C. Plaque fissuring the cause of acute myocardial infarction, sudden ischaemic death and crescent angina. Br Heart J. 53:1985;363-373
10. DeGraba T.J., Siren A.L., Penix L., et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke. 29:1998;1405-1410
11. Diet F., Pratt R.E., Berry G.J. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 94:1996;2756-2767
12. Dzau V.J. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens. 12:(Suppl 4):1994;S3-S10
13. Ehlers M.R.W., Riordan J.F. Angiotensin-converting enzyme new concepts concerning its biological role. Biochemistry. 28:1989;5311-5318
14. European Carotid Surgery Trialists' Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 351:1998;1379-1387
15. Executive Committee for the Asymptomatic Carotid Atherosclerosis (ACAS) study. Endoarterectomy for asymptomatic carotid artery stenosis. JAMA. 273:1995;1421-1428
16. Feeley T.M., Leen E.J., Colgan M.P., et al. Histologic characteristics of carotid artery plaque. J Vasc Surg. 13:1991;719-724
17. Fukuhara M., Geary R.L., Diz D.I. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension. 35:2000;353-359
18. Fuster V., Badimon L., Badimon J.J., et al. The pathogenesis of acute coronary artery disease and acute coronary syndromes. N Engl J Med. 326:1992;242-250
19. Geisterfer A.A.T., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 62:1988;749-756
20. Gibbons G.H., Pratt R.E., Dzau V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 90:1992;456-461
21. Golledge J., Greenhalgh R.M., Davis A.H. The symptomatic carotid plaque. Stroke. 31:2000;774-781
22. Hatsukami T.S., Ferguson M.S., Beach K.W., et al. Carotid plaque morphology and clinical events. Stroke. 28:1997;95-100
23. Itoh H., Mukoyama M., Pratt R.E., et al. Multiple autocrine growth factors mutate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 91:1993;2268-2274
24. Jander S., Sitzer M., Schumann R., et al. Inflammation in high-grade carotid stenosis a possible role for macrophages and T cells in plaque destabilization. Stroke. 29:1998;1625-1630
25. Lammie G.A., Sandercock P.A.G., Dennis M.S. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke. 30:1999;1319-1325
26. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850
27. Loree H.M., Kamm R.D., Stringfellow R.G., et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 71:1992;850-858
28. Naftilan A.J., Pratt R.E., Dzau V.J. Induction of platelet-derived growth factor A chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1419-1424
29. Naftilan A.J., Pratt R.E., Eldridge C.S., et al. Angiotensin II induced c-fos expression in smooth muscle via transcriptional control. Hypertension. 13:1989;706-711
30. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Classification of cardiovascular disease III. Stroke. 21:1990;637-676
31. North American Symptomatic Carotid Endoarterectomy Trial (NASCET) Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 325:1991;445-453
32. Ogata J., Masuda J., Yutani C., et al. Rupture of atheromatous plaque as a cause of thrombotic occlusion of stenotic internal carotid artery. Stroke. 21:1990;1740-1745
33. Ohishi M., Ueda M., Rakugi H. Enhanced expression of angiotensin- converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens. 15:1997;1295-1302
34. Ohishi M., Ueda M., Rakugi H. Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. J Hypertens. 17:1999;547-553
35. Osterrieder, W, Muller, RK, Powell, JS, et al Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 1991;18 (Suppl. IV):II60-4
36. Pepine, CJ. Angiotensin converting enzyme inhibition and coronary artery disease. J Hypertens 1994;12(Suppl 4):S65-71
37. Powell J.S., Clozel J.-P., Muller P.K.M. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188
38. Richardson P.D., Davies M.J., Born G.V. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:1989;941-944
39. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s. Nature. 362:1993;801-809
40. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 340:1999;115-126
41. Schuh J.R., Blehm D.J., Friedrich G.E., et al. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest. 91:1993;1453-1458
42. Seeger J.M., Barratt E., Lawson G.A., et al. The relationship between carotid plaque composition, plaque morphology and neurologic symptoms. J Surg Res. 58:1995;330-336
43. Sitzer M., Muller W., Siebler M., et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 26:1995;1231-1233
44. Van der Wal A.C., Becker A.E., Van der Loos C.M., et al. Site of initial rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of dominant plaque morphology. Circulation. 89:1994;36-44
45. von Maravic C., Kessler C., von Maravic M., et al. Clinical relevance of intraplaque haemorrhage in the internal carotid artery. Eur J Surg. 157:1991;185-188